![](/img/cover-not-exists.png)
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality
Eriksson, Jan W., Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Nyström, Thomas, Norhammar, AnnaLanguage:
english
Journal:
Diabetes Research and Clinical Practice
DOI:
10.1016/j.diabres.2016.04.055
Date:
May, 2016
File:
PDF, 2.08 MB
english, 2016